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Abstract
The trend in conducting successful biomedical research is shifting from individual academic labs 
to coordinated collaborative research teams. Teams of experienced investigators with a wide 
variety of expertise are now critical for developing and maintaining a successful, productive 
research program. However, assembling a team whose members have the right expertise requires a 
great deal of time and many resources. To assist investigators seeking such resources, the Indiana 
Clinical and Translational Sciences Institute (Indiana CTSI) created the Project Development 
Teams (PDTs) Program to support translational research on and across the Indiana University-
Purdue University Indianapolis, Indiana University, Purdue University, and University of Notre 
Dame campuses. PDTs are multidisciplinary committees of seasoned researchers who assist 
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investigators, at any stage of research, in transforming ideas/hypotheses into well-designed 
translational research projects. The teams help investigators capitalize on Indiana CTSI resources 
by providing investigators with, as needed, mentoring and career development; protocol 
development; pilot funding; institutional review board, regulatory, and/or nursing support; 
intellectual property support; access to institutional technology; and assistance with biostatistics, 
bioethics, recruiting participants, data mining, engaging community health, and collaborating with 
other investigators.
Indiana CTSI leaders have analyzed metrics, collected since the inception of the PDT Program in 
2008 from both investigators and team members, and found evidence strongly suggesting that the 
highly responsive teams have become an important one-stop venue for facilitating productive 
interactions between basic and clinical scientists across four campuses, have aided in advancing 
the careers of junior faculty, and have helped investigators successfully obtain external funds.
In 1992, Rosenfield reported a trend in scientific research towards transdisciplinary research 
teams.1 Over the last several decades, biomedical research has become increasingly 
dependent on elucidating complex biological and disease processes through sophisticated 
study designs and novel technologies. The expertise required to conduct such high-impact 
studies rarely exists in a single laboratory and usually requires the collaboration of 
investigators and team members with diverse expertise.2 Such fundamental differences in 
the traditional and contemporary research cultures could become major barriers to 
developing truly impactful, translational science within and across academic institutions. 
Any serious attempt at the transformation of the academic research infrastructure and culture 
must facilitate transdisciplinary collaboration for future research to be successful.
Program Origins and Description
In 2006, as the leaders of the Indiana Clinical and Translational Sciences Institute (Indiana 
CTSI) were building the infrastructure and resources needed to apply for a Clinical and 
Translational Science Award (CTSA), they knew the institute required a component that 
would facilitate collaboration among investigators working in multidisciplinary teams. 
Specifically, the leaders wanted to address the oft-cited problem that “clinical and basic 
scientists don't really communicate.”2 Previously, in 2005, the Pediatrics Department at 
Indiana University (IU) School of Medicine and the IU Simon Cancer Center had 
established project development teams (PDTs), composed of clinical scientists, basic 
scientists, and biostatisticians, that were successful in helping investigators design and 
implement translational research projects. The primary investigator (PI) on the CTSA grant 
(A.S.) expanded these two existing programs to help facilitate research across all four 
campuses in the Indiana CTSI (the Indiana University-Purdue University Indianapolis 
[IUPUI], IU, Purdue University, and University of Notre Dame campuses).
The Indiana CTSI PDTs are multidisciplinary committees composed of seasoned researchers 
who assist investigators in developing ideas/hypotheses into well-designed translational 
research projects. Each PDT is coordinated by a chair and a project manager. The chair of 
each PDT is a senior faculty member who is compensated for 10% of his or her time by the 
Indiana CTSI to lead the team. This faculty member is responsible not only for selecting the 
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standing members of his or her team (typically 6-8 academics) but also for making 
recommendations for and inviting ad hoc reviewers when needed. Project managers are staff 
members who devote between 25 and 50% of their time to the Indiana CTSI, depending on 
the PDT that they serve. These individuals are responsible for scheduling the investigators 
and preparing them to present to the teams. They also maintain all communications between 
the Indiana CTSI and the investigator as well as track the projects from application to grant 
submission. Most teams include basic and clinical scientists as well as members with other 
expertise (e.g., intellectual property). The teams function as a “one stop shop” for 
investigators by providing, as needed, mentoring and career development; protocol 
development; pilot funding; assistance with biostatistics; institutional review board, 
regulatory, and/or nursing support; bioethical consults; assistance with recruiting research 
participants; electronic medical records data mining; intellectual property support; means to 
engage community health; ways of collaborating with other investigators; and access to over 
60 translational technology resources on the IUPUI, IU, Purdue University, and University 
of Notre Dame campuses. The PDTs are available to help investigators at any stage of their 
research from preclinical to community engagement. The PDT Program has some 
similarities to the innovative “Studio” program at the Vanderbilt Institute for Clinical and 
Translational Research3; however, some key differences set these two programs apart (see 
List 1).
The purpose of this article is to provide an account of the PDT Program after five years 
(2008/09 – 2012/13) of existence both to demonstrate its effectiveness and to share our 
experiences with leaders of other centers who may be interested in developing similar 
programs.
Overall Purpose for and Process of PDTs
As they were designing the PDT Program, Indiana CTSI leaders considered, based on their 
own personal experiences, several critical obstacles that investigators interested in building 
multidisciplinary, translational research projects face: (1) a deficiency of expert guidance 
and mentorship in multidisciplinary research; (2) a lack of coordinated, easy access to 
resources and/or to the institutional research infrastructure; (3) insufficient protected time 
for experts to assist new investigators; (4) a complex web of multiple regulatory 
submissions; (5) a lack of coordinated access to patient populations and health systems for 
recruiting research participants; and (6) a scarcity of readily accessible pilot funds for 
generating preliminary data or addressing critiques in extramural grant applications. 
Currently, the burden of navigating these multiple barriers lies solely or predominately on 
the PI. Further, designing multidisciplinary, translational, sound research is time-intensive 
and very laborious. Often investigators do not know how to navigate the infrastructure of 
their institutions to maximize their access to assistance, resources, and collaborators. The 
PDT Program addresses this impediment by bringing necessary resources together in a 
single venue through which investigators have the opportunity to present their project to a 
team of academics with diverse expertise.
Although we have described the PDT process elsewhere,4 we have also provided a brief 
summary here. To initiate PDT assistance, an investigator accesses the Indiana CTSI hub 
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Webpage5 and then clicks on, first, the “Research resources” link and, second, the “Project 
Development Teams” link. This link provides access to information the investigator needs to 
submit a simple online application. A well-designed, complete study protocol is not required 
for application; the investigator can come to a team with anything from a hypothesis to a full 
grant proposal. No investigator is denied access to PDT assistance; rather, the application 
serves as a means to understand the investigator's needs and to match him or her with the 
most appropriate team. The project is assigned to a PDT whose members have the right 
expertise (Table 1), and if additional expertise is necessary members from other PDTs or ad 
hoc reviewers may be invited to join the lead team to provide specific expertise. Next, the 
project manager schedules a meeting for the PDT and the investigator. Approximately one 
week prior to the meeting, the PDT members receive and review the application and any 
other materials the investigator provides. Detailed reviews are not required prior to the 
meeting, so each team member usually spends about an hour preparing. While the members 
are reviewing the proposal materials, the investigator is putting together his/her 10 – 15 
minute presentation. At the review meeting, the PI presents an overview of his or her 
research proposal to the PDT, and the PDT members provide the PI with advice, guidance, 
and information about and/or access to necessary resources, including occasionally funding. 
The one-hour meeting facilitates a dynamic interaction between the investigator and the 
PDT members. Because the teams consist of experienced researchers as well as 
representatives from many Indiana CTSI resources and programs, the meeting allows the PI 
an opportunity to efficiently gather input from multiple individuals to strengthen his or her 
particular project.
The Benefits of the PDT Program
After five years, the impact of the PDT on research at the Indiana CTSI institutions is 
emerging. Below, we present the results of surveys of PDT members and of investigators 
who have brought projects to a PDT. Since the formation of the Indiana CTSI during the 
2008-2009 academic year, the PDT Program has reviewed 571 projects along the 
translational spectrum: 244 T1(translation to humans); 257 T2(translation to patients); and 
70 T3(translation to practice and community). Further, the number of PDTs has increased 
from four to seven (Table 1) in order to provide comprehensive guidance and assistance at 
each of these different stages of research and to better accommodate researchers at all 
Indiana CTSI partner institutions.
Team mentoring
The Indiana CTSI has recognized the importance of providing team guidance both to 
enhance the development of research proposals and to accelerate the process of external 
funding procurement. As mentioned above, the Indiana CTSI leaders strategically selected 
members of each PDT from a variety of backgrounds and fields of expertise (e.g., 
nanotechnology or children's health research) as well as from key institutional programs 
(e.g., biostatistics or bioethics) across all 4 CTSI campuses. The PDT Program facilitates a 
comprehensive review of research projects by a multidisciplinary group of well-established 
researchers and helps PIs avoid pitfalls that may render a project less likely to attain external 
funding. Specifically, the PDTs have played an active role in the creation of 35 new 
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collaborations between basic and clinical scientists between 2008 and June, 2014. The PDT 
Program is especially beneficial for junior investigators because it provides networking 
opportunities and access to potential mentors from a variety of disciplines. Notably, junior 
investigators are often referred to the PDT Program by their departmental chairs or other 
senior faculty to receive much-needed input prior to a grant submission.
The PDT Program and its interdisciplinary team mentoring approach have led to protocol 
design improvements and the streamlining of project milestones. All investigators who have 
brought research to a PDT, including those who received no pilot funds, have acknowledged 
these benefits. In fact, program evaluation survey results from 2013 - 2014 indicate that 72% 
of researchers who did not receive funding but interacted with the PDTs felt that the 
guidance they received had a positive impact on their research approach, and 73% made 
changes to their protocols in line with the feedback they received from the team. One junior 
faculty member conducting research in Kenya submitted a grant application that was 
initially unsuccessful. She met with the Behavior and Population Sciences PDT by phone 
while she was in Kenya and then continued to receive assistance via e-mail and other phone 
conferences. After incorporating much of the multidisciplinary guidance she received from 
the PDT and reapplying for a National Institutes of Health grant, the investigator's 
resubmission was funded.
Single point of access to resources
Research projects now encompass multiplexed approaches of data gathering methods. 
Commonly, a single study proposal will encompass several techniques and/or stages of 
translational research. Traditionally, the PIs bore all or most of the responsibility for finding 
needed resources located outside of their laboratory/research group; however, today, given 
the variety of techniques used in any given study, the number of resource contacts required 
has increased. Scientists now need to be in contact with basic as well as clinical researchers, 
bioinformaticians, statisticians, technology transfer agents, bioengineers, regulatory support 
agents, study coordinators, health economic analysts, biotech company representatives, and 
bioethicists (just to name a few) to plan a cutting edge translational research approach.
By engaging with the PDT, PIs no longer need to search out resource contacts. If expertise is 
required outside of the PDT, the project manager or one of the team members makes the 
initial contact for the PI and continues to be available if future assistance is needed.
The 94 investigators who took advantage of the PDT Program during the 2013 funding 
period reported that they received 787 “services” or program/resource connections from 
Indiana CTSI programs. The mean number of program/resource connections was 8.37 and 
the median was 8 compared to a mean of 1.96 for all investigators6 (median 1). These data 
suggest the PDT Program is providing an efficient process for investigators to connect with 
other Indiana CTSI resources.
Responsiveness
Scientific research is a dynamic process that requires flexibility and ongoing problem 
solving. From the initiation of the PDT Program, responding quickly to evolving 
investigator needs has been a key goal.
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The PDT Program's responsiveness has been demonstrated in both the duration and the 
number of meetings for each PDT. Initially, each team determined how many times per 
month and for what duration they would meet. However, adjustments have been made to 
compensate for the high demand. For example, one of the teams initially needed to review 
projects only on a biannual basis, but by the end of the second year, that team adopted a 
rolling review process, now meeting monthly, to expedite the reviews and to enable PIs to 
meet external grant deadlines. Now the average timeline from application to team meeting 
for all investigators is approximately 4 weeks.
Further, the amount of time that elapses between the PDT meeting and distribution of the 
feedback to the PI is on average 12 ± 3 days. Taken together with the time from application 
to meeting, a PI can request PDT assistance, meet with the team, and receive feedback in 
approximately 6 weeks.
Breaking down institutional silos
The PDT Program has successfully connected the three major research institutions, located 
on four campuses, across the state of Indiana. Each campus has unique research strengths, 
particular patterns of investigator interactions, and a distinct institutional culture. At least 
one PDT is located on each campus, enabling the teams to leverage the specific research 
expertise and knowledge of each locale. All PDTs include members from the home campus 
as well as from the other universities, facilitating institutional interactions. In addition, 
depending on project goals, investigators can access any PDT (i.e., the one with the most 
relevant research expertise)—not just the PDTs located on their own campus. To date, 73 
investigators have consulted a PDT beyond their campus. More importantly, institutional 
silos are minimized by seamlessly providing investigators at all campuses wider access to 
comprehensive expertise, advice, and resources such as access to pilot funding and clinical 
populations who may serve as participants in research. The broad and robust network of 
translational research initiated by the PDT Program has allowed a collaborative environment 
to flourish and has diminished traditional cross-institutional barriers within Indiana.
Data-driven management
From the beginning of the program, the Indiana CTSI Translational Sciences Research 
Officer (T.J.S.) implemented a data system to track all projects evaluated by the PDTs, using 
the capabilities of Research Electronic Data Capture (REDCap), built by Vanderbilt,7 for 
administrative and evaluation purposes. The PDT manager also created a simple entry form 
using REDCap so that investigators could submit applications and progress reports with 
minimal effort. Using this system, extensive data are systematically and consistently 
collected from hundreds of projects, allowing the manager to assess PDT Program progress. 
Milestones and metrics are developed for each PDT project that receives pilot funding; the 
program manager evaluates the metrics at designated reporting intervals. This close 
monitoring allows the program manager to quickly assist with projects that are not achieving 
milestones as expected. If the intervention is unsuccessful, projects (and their funding) are 
ended early. The REDCap system also produces information about the individual 
performance of each of the PDTs, as well as the overall effectiveness of pilot funding, 
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providing a continuous evaluation mechanism for the Indiana CTSI to best manage its pilot 
investment.
Funding
Overall success in generating extramural funds—Recently, the Indiana CTSI 
conducted a return on investment analysis, examining the outcome of grant applications for 
those individuals receiving pilot funding from the PDT Program. Figure 1A shows that a 
total of $6,310,646 invested (May 2008- June 2014) in pilot funding and administrative 
costs (including PDT members’ salary support) realized a return on investment of—for 
every $1— more than $14 from grants in the amount of $92,824,425. The PDT has also 
fostered new intellectual property, including 6 licenses granted to industry, 19 disclosures 
filed, 28 patents (issued or pending), and 10 startup companies formed. Additionally, the 
PDTs have funded projects across the translational spectrum from T1 – T3. Figure 1B shows 
the total investment and total return for projects at each phase: T1 (244), T2 (257), and T3 
(70).
Assisting junior investigators—Assistant professors have the most difficulty in 
obtaining external funding for research. The 2005 NIH report, Bridges to Independence, 
states that many investigators experience a 4- to 7-year lag between taking an academic 
position and receiving their first research grant.8 For many assistant professors, this lag may 
mean the difference between staying in research and being forced to leave. Since the 
publication of Bridges to Independence, research funding opportunities and budgets have 
diminished,9 resulting in an even more challenging and competitive research environment. 
Because of the special vulnerability of assistant professors, we examined the impact of the 
PDT Program on these investigators. Table 2 shows some of the metrics for junior faculty 
who received pilot funding support from the PDTs from 2008 through 2011. These data 
indicate that 24 (37%) of the 65 junior investigators who received pilot funding were 
successful in obtaining additional grant funding within an average of 18 months after their 
initial meeting with a PDT. This data, coupled with the average years at rank for the 
investigators (2.5), demonstrates that the PDT Program is able to facilitate the procurement 
of funding for junior faculty in just about 4 years.
PDT Member Satisfaction
The PDT has benefitted the Indiana CTSI (in terms of return on investment) and 
investigators (in terms of facilitating mentoring and leveraging resources), but also team 
members. Five percent of each team member's salary supports their work on the team (10% 
for each team chairperson). Additionally, a recent anonymous survey revealed that members 
derive satisfaction from being a part of a team (Table 3). The members’ satisfaction helps 
keep them engaged in the program and wanting to assist investigators.
Lessons Learned and Next Steps
Since its initiation in May of 2008, the PDT Program has experienced many challenges as 
well as successes. First, we realized that investigators do not always recognize what is 
needed for a project to be successful. After the PDT meeting, the overall study design and 
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resources necessary might significantly change, thus requiring additional PDT meetings. We 
have found that assigning one of the team members to be a primary contact helps to 
facilitate each investigator's progress between meetings. We also noted that the variation in 
presentations across investigators resulted in inefficient meetings. In the last year (2013), we 
have created and implemented a presentation template with specific headings that has 
greatly improved the flow and productivity of investigator-team discussions.
Probably the greatest lesson learned has been coming to understand the different cultures at 
each institution. One of the major goals of the PDTs is to break down institutional silos 
across the state. The fact that the PDTs are focused on themes means that many times we 
have investigators from one institution coming to a PDT at another institution, and the 
expectations of the team members on how the process should occur have varied. To aide in 
continuity, the Indiana CTSI recently assigned a “navigator” to each of the 4 campuses. The 
navigators stay in constant communication with one another, and at least two navigators sit 
as members on all PDTs. These connections represent a vital means of more fully promoting 
productive interactions across the three universities and four campuses.
Going forward, we hope to continue building a strong research community across the state. 
We understand the PDT Program may not be feasible at all institutions, at least not to the 
scale at the Indiana CTSI, as significant financial resources and faculty time are required 
yet, we have helped a variety of CTSA institutions develop and establish a smaller-scale 
PDT Program and hope to inspire other such collaborative programs.
Summary
The mission of the Indiana CTSI is to successfully transform clinical and translational 
research and improve health care across Indiana and beyond. The PDT Program has helped 
accomplish this mission by creating networks of multidisciplinary investigators across the 
three major research universities within Indiana. Over the five years of its existence, the 
PDT Program has expanded and continually improved to bridge the myriad disciplines that 
contribute synergistically to translational research. The PDT Program has accelerated the 
process of research from initial concept to external funding acquisition facilitating T1 to T3 
research using this unique team approach.
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List 1 Similarities and Differences Between the University of Vanderbilt 
School of Medicine's Studio Program and The Indiana Clinical and 
Translational Sciences Institute's Project Development Team (PDT) 
Program
Similarities
Both programs...
• Are designed to facilitate the development of improved research and/or science.
• Involve team members with a variety of expertise.
• Facilitate investigator access to the expert advice needed for developing a 
project.
• Involve investigators-in-training as participating members of the review team, 
so they may gain experience.
• Do not charge investigators for using the service.
Key differences
Membership
• Studio membership is ad hoc, recruited for specific projects (30% of Studio 
panel members participated in only one Studio panel).
○ Has the advantage of customized expertise to match the research.
○ Requires additional effort to recruit.
○ May add some overhead in terms of time to the meeting as members who 
are not familiar with one another develop an understanding of shared and 
divergent ideas about research.
• • The PDT Program uses fixed membership teams.
○ Recruitment occurs just once (participation is tracked and membership 
changes as needed over time).
○ Team members develop knowledge of shared and divergent ideas about 
research, which facilitates their work together.
○ Expertise can be added as needed.
Ability to provide funding
• Studio panels do not provide pilot grant funds; investigators apply for funding 
through a separate process.
• The PDTs may themselves provide pilot grant funding to projects deemed ready 
to implement.
Organization of panels
• Studio panels are organized by research stage.
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• PDTs are organized by research stage (preclinical, clinical), by unique projects 
at each institution (Purdue, Notre Dame, Indiana University), by research area 
(behavioral, community, urban health), and by population (pediatrics, 
community and urban health).
Compensation
• Studio members are paid an honorarium of $150 and receive a box lunch.
• 5% of each team member's salary and 10% of each team chairman's salary 
comes from PDT participation.
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Figure 1. 
A graph depicting (A) the return on investment (ROI) from May 2008 to June 2014 for 2008 
to 2013 Project Development Team (PDT) funded projects; ROI was greater than $14 for 
every $1 invested, including pilot funding and PDT members’ salaries; and (B) the overall 
total dollars invested in PDT projects, including administrative costs and the total return on 
investment in grant dollars represented by translational phase (See Table 1 for translational 
phase descriptions)
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